BOT 5.48% 34.5¢ botanix pharmaceuticals ltd

Our Antimicrobial is underrated. I’m super keen on Btx1801,...

  1. 266 Posts.
    lightbulb Created with Sketch. 161
    Our Antimicrobial is underrated. I’m super keen on Btx1801, after having several email conversations with Mark Blaskovich at UQ. See his bio here.
    https://researchers.uq.edu.au/researcher/1614

    Btx1801 disrupts the biofilm of gram positive bacteria, meaning that resistance is not able to be developed. See article below

    https://www.biospace.com/article/btx-1801-kills-superbugs-without-resistance-world-first-study/
    https://hotcopper.com.au/data/attachments/6074/6074591-365fca082b5ac11b48d874a96f5cb8e7.jpg

    Development of antimicrobials is never going to be easy, but the upside is enormous. The phase 2b study is just one example of its use - if Blaskovich/Botanix can prove this works without long-term resistance it will be a global groundbreaking product(s).

    All my own opinion, dyor etc.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.5¢
Change
-0.020(5.48%)
Mkt cap ! $543.4M
Open High Low Value Volume
35.5¢ 35.5¢ 34.0¢ $4.566M 13.13M

Buyers (Bids)

No. Vol. Price($)
11 410003 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 346713 8
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.